Cargando…
Potential Impacts of Hydralazine as a Novel Antioxidant on Cardiovascular and Renal Disease—Beyond Vasodilation and Blood Pressure Lowering
Hydralazine is a traditional antihypertensive drug that was developed several decades ago. Its most well-known effect is blood pressure lowering by arterial vasodilation. While mainly used an adjunct treatment for clinical hypertension or chronic heart failure, this old drug has also shown potential...
Autores principales: | Chang, Ting-Ting, Chen, Jaw-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686999/ https://www.ncbi.nlm.nih.gov/pubmed/36421409 http://dx.doi.org/10.3390/antiox11112224 |
Ejemplares similares
-
Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
por: Al‐Mohammad, Abdallah
Publicado: (2019) -
Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments
por: Leening, Maarten J. G., et al.
Publicado: (2018) -
Comparison of Hydralazine and Labetalol to lower severe hypertension in pregnancy
por: Khan, Ayesha, et al.
Publicado: (2017) -
Hydralazine target: From blood vessels to the epigenome
por: Arce, Claudia, et al.
Publicado: (2006) -
Lowering Intraocular Pressure: A Potential Approach for Controlling High Myopia Progression
por: Wang, Peiyuan, et al.
Publicado: (2021)